DEPRESSION, ANXIETY AND SOCIAL PROBLEMS AMONG MARRIED WOMEN WITH POLYCYSTIC OVARIAN DISEASE
Main Article Content
Keywords
PCO, anxiety, depression, social problems
Abstract
Background: The most prevalent endocrine abnormality is PCOS. Hormonal conditions like those that accompany polycystic ovarian syndrome (PCOS), wherever variations in appearance and needing to cope with such a range of other problems emerge as a result of this disease, frequently lead to mental health difficulties.
Objective: To determine the prevalence of depression, anxiety and social problems among married women with polycystic ovarian disease.
MATERIAL AND METHODS: This descriptive cross-sectional study was conducted in (OPD) of Gynecology and Obstetrics at Taluka Hospital Kotri, during Six months. Married women aged 18-40 years having PCO disease diagnosed more than 1 years were included. Depression and anxiety were measured using (DASS-21) scale. Data was collected via study proforma and SPSS version 26 was used for the analysis.
Results: A total of 221 women with polycystic ovarian syndrome (PCOS) were included in the study. The most common age group among the patients was 24-26 years, accounting for 87.8% of the participants. The majority of the women (55.2%) had completed education ranging from primary to higher levels. In terms of depression levels among women with PCOS, half of the participants (52.0%) experienced mild depression, while 13.6% had severe depression and 2.7% had very severe depression. Regarding anxiety levels, 54.8% of the women had mild anxiety, whereas only 3.6% experienced very severe anxiety.
Conclusion: The study concludes that depression and anxiety were significantly more prevalent among women with polycystic ovarian syndrome (PCOS). Additionally, these women were found to encounter various social chall
References
2. Vos T, Flaxman AD, Naghavi M. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2013;380(9859):2163–2196.
3. Fatima U, Naz M, Zafar H, Fatima A, Yasmeen A. Psychological complications of polycystic ovarian syndrome and women’s health. International Journal of Research in Medical Sciences. 2020 Jan;8(1):159.
4. Dennett CC, Simon J. The role of polycystic ovary syndrome in reproductive and metabolic health: overview and approaches for treatment. Diabetes Spectrum. 2015 May 1;28(2):116-20.
5. Akram M, Roohi N. Endocrine correlates of polycystic ovary syndrome in Pakistani women. J Coll Physicians Surg Pak. 2015;25: 22–26.
6. JAVED R, DAUD B, JAHAN N. Frequency and Factors of Polycystic Ovarian Syndrome in College Going Females. PJMHS 2020;14;3;865-68
7. Yin X, Ji Y, Chan CL, Chan CH. The mental health of women with polycystic ovary syndrome: a systematic review and meta-analysis. Archives of Women's Mental Health. 2020 Jun 9:1-7.
8.. Aliasghari F, Mirghafourvand M, Charandabi SM, Lak TB. The predictors of quality of life in women with polycystic ovarian syndrome. International journal of nursing practice. 2017;23(3):e12526.
9 Moulana M. Persistent risk: psychological comorbidity in polycystic ovary syndrome. Endocrinol Metab Int J. 2020;8(6):139-141.
10.Alur-Gupta S, Chemerinski A, Liu C, Lipson J, Allison K, Sammel MD, Dokras A. Body-image distress is increased in women with polycystic ovary syndrome and mediates depression and anxiety. Fertility and sterility. 2019;1;112(5):930-8.
11. Hung JH, Hu LY, Tsai SJ, Yang AC, Huang MW, Chen PM, et al. Risk of psychiatric disorders following polycystic ovary syndrome: a nationwide population-based cohort study. PloS One. 2014;9: e97041.
12. Rashid R, Mir SA, Kareem O, Ali T, Ara R, Malik A, Amin F, Bader GN. Polycystic ovarian syndrome-current pharmacotherapy and clinical implications. Taiwanese Journal of Obstetrics and Gynecology. 2022 Jan 1;61(1):40-50.
13. Sidra S, Tariq MH, Farrukh MJ, Mohsin M. Evaluation of clinical manifestations, health risks, and quality of life among women with polycystic ovary syndrome. PloS one. 2019 Oct 11;14(10):e0223329.
14. Brewer M, Pawelczak M, Kessler M, Shah B. A review of polycystic ovarian syndrome in adolescents. Minerva Pediatr. 2010;62: 459–473.
15. Kaur SP, Sharma S, Lata G, Manchanda S. Prevalence of anxiety, depression and eating disorders in women with polycystic ovarian syndrome in North Indian Population of Haryana. Galore Int J Health Sci Res. 2019;4(4):61-7.
16. Al-Naqeeb AA, Zedian MA, Mohammad A. impact of polycystic ovarian syndrome on general health related-quality of life among a sample at “maternity and children teaching hospital” in diwaniyah city-iraq. Wiadomosci lekarskie (Warsaw, Poland: 1960). 2022;75(4 pt 1):836-41.
17. Zehra S, Arif A, Anjum N, Azhar A, Qureshi M. Depression and anxiety in women with polycystic ovary syndrome from Pakistan. Life Sci J. 2015;12: 1–4
18. Kala K, Sujata N, Sujatha C, Dayanand R, Kumar G. A study of clinical manifestations of PCOS among obese and non-obese rural women.Indian Journal of Basic & Applied Medical Research. 2013;8(2):946-51.
19. Balen AH, Conway GS, Kaltas G, Techatraisak K, Manning PJ, West C et al .Polycystic ovarian syndrome: The spectrum of disorder in 1741 patients. Hum Reprod 1995;10:2107-11.
20. Wang Y, Ni Z, Li K. The prevalence of anxiety and depression of different severity in women with polycystic ovary syndrome: a meta-analysis. Gynecological Endocrinology. 2021 Dec 2;37(12):1072-8.
21. Accortt EE, Freeman MP, Allen JJ. Women and major depressive disorder: clinical perspectives on causal pathways. J Womens Health (Larchmt) 2008;17:1583-1590
22. Deeks AA, Gibson-Helm ME, Teede HJ. Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation. Fertil Steril. 2010;93:2421–2423